NCT06737393 is a NA clinical trial of Backfill in Patient Discharge, sponsored by University of Tennessee.

Who is sponsoring NCT06737393?

NCT06737393 is sponsored by University of Tennessee.

What drugs are being tested in NCT06737393?

Interventions in NCT06737393: Backfill.

What condition does NCT06737393 study?

NCT06737393 studies Patient Discharge, Urinary Complication.

Is NCT06737393 still recruiting?

NCT06737393 is currently recruiting now. Last updated 17 December 2024.

Last reviewed 2024-12-17 · How we verify

NCT06737393

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge

Recruiting now NA Last updated 17 December 2024

What this trial tests

NA trial testing Backfill in Patient Discharge in 112 participants. Currently enrolling.

Timeline

1 January 2025

Primary endpoint
1 January 2026

1 January 2026

Quick facts

Lead sponsor	University of Tennessee
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	112
Start date	1 January 2025
Primary completion	1 January 2026
Estimated completion	1 January 2026
Sites	1 location across United States

Drugs / interventions tested

Backfill

Conditions studied

Patient Discharge — all drugs for Patient Discharge →
Urinary Complication — all drugs for Urinary Complication →

Sponsor

University of Tennessee

Who can join

Adults 18 to 80, female only, with Patient Discharge or Urinary Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Patient Discharge

Currently open trials in the same condition.

NCT06655337 — Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) · NA · recruiting

Other University of Tennessee trials

Trials by the same sponsor.

NCT07465432 — Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries · Phase 4 · recruiting
NCT07225725 — Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) · NA · not yet recruiting
NCT07227519 — Effects of UPF Warning Labels on Social Media Among Teens and Young Adults · NA · not yet recruiting
NCT06850857 — Multi-Institutional IMPACT Validation · enrolling by invitation
NCT06745180 — Making Healthy Habits Stick · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06737393 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Tennessee
Last refreshed: 17 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing